| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 02/24/2005 | WO2005016909A1 Substituted thiophenes and uses thereof |
| 02/24/2005 | US20050043349 1-Alkyl-1-azoniabicyclo' 2.2.!octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 02/24/2005 | US20050043317 Biaryl heterocyclic compounds and methods of making and using the same |
| 02/24/2005 | DE10334724A1 N-Biarylamide N-biaryl |
| 02/24/2005 | CA2535652A1 Substituted thiophenes and uses thereof |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/22/2005 | US6858608 Chemical derivatives and their application as antitelomerase agents |
| 02/17/2005 | WO2005014517A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/17/2005 | US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038070 Tetrahydroquinoline derivatives; modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 02/17/2005 | CA2533174A1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/16/2005 | EP1506205A2 Novel azacyclic ethynyl derivatives |
| 02/16/2005 | EP1064285B1 Novel cephalotaxane derivatives and process for their preparation |
| 02/16/2005 | CN1189174C Pharmaceutical compositions contg. cinchonine dichlorhydrate |
| 02/10/2005 | WO2005012299A1 N-biarylamides |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005011675A1 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 02/10/2005 | CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
| 02/08/2005 | US6852716 Central nervous system disorders; psychological disorders |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/03/2005 | WO2005009928A2 Preparation and use of alkylating agents |
| 02/03/2005 | US20050026991 mono-N-substituted amide monohydroxyamide derivatives, e.g., 1-Benzyl-3-(3,4-dichloro-benzyloxy)-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide, that modulate levels of gene expression in cellular systems, including cancer cells |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | CA2538520A1 Preparation and use of alkylating agents |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849620 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 01/27/2005 | WO2005007628A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007111A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007094A2 Asthma and allergic inflammation modulators |
| 01/27/2005 | US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 01/27/2005 | US20050020660 For example, 3-(3-methoxy-1-azabicyclo[2.2.2]oct-3-yl)-1,1-diphenyl-2-propyn-1-ol, 3-[(3R)-3-methoxy-1-azabicyclo [2.2.2]oct-3-yl]-1,1-diphenyl-2-propyn-1-ol; particularly suited for treating urinary incontinence |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499616A1 Heterocyclic compounds |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499311A1 Substituted benzazoles and use thereof as raf kinase inhibitors |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | CN1571787A Quinuclidine derivatives processes for preparing them and their uses as M2 and/or M3 muscarinic receptor inhibitors |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1497272A2 Method of preparing amine stereoisomers |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/18/2005 | US6844355 Stereoisomer chromatographic purification; modulating sodium and potassium channel function; cardiac arrhythmia; gastro-intestinal motility |
| 01/13/2005 | US20050009870 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 01/13/2005 | US20050009808 Azabicyclo compound matrix metalloprotease inibitor and skin preparation |
| 01/13/2005 | US20050009805 Quaternary ammonium 1,4-benzothiazepinedione derivatives useful for treatment and prevention of hyperlipidemia, cholestasis-accompanying hepatopathy, particularly primary biliary cirrhosis and primary sclerosing cholangitis, and obesity and fatty liver. |
| 01/12/2005 | EP1189913B1 Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 01/12/2005 | EP0991628B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/06/2005 | WO2005000305A1 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2005000250A2 Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor |
| 01/06/2005 | WO2004096800A3 Quinuclidine derivatives binding to mucarinic m3 receptors |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/04/2005 | US6838464 Inhibitor of cyclin-dependent kinase |
| 12/30/2004 | US20040266816 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 12/30/2004 | US20040265248 Biphenylene compounds |
| 12/29/2004 | WO2004113391A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 12/29/2004 | CA2529257A1 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | CA2529256A1 Methods and compositions for treating amyloid-related diseases |
| 12/23/2004 | WO2004110609A2 Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides |
| 12/23/2004 | CA2529071A1 Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides |
| 12/22/2004 | EP1487835A1 Amides of acetic and propionic acids |
| 12/22/2004 | EP1487834A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor |
| 12/22/2004 | EP1436266A4 Methods and compositions of novel triazine compounds |
| 12/21/2004 | US6833478 N,N-dinitramide salts as solubilizing agents for biologically active agents |
| 12/16/2004 | WO2004108668A2 Alpha-7 neuronal nicotinic receptor ligands: compositions and methods of use |
| 12/16/2004 | WO2004108636A2 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 12/16/2004 | WO2004108086A2 HYDANTOIN DERIVATIVES AS INHIBITORS OF TUMOR NECROSIS FACTOR-α CONVERTING ENZYME (TACE) |
| 12/16/2004 | WO2004076449A3 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 12/16/2004 | US20040254231 Antiinflammatory agents; alcoholism; antiallergens; chronic obstructive pulmonary disease; cardiovascular disorders; antiarthritic agents; autoimmune disease; chronic fatigue syndrome; multiple sclerosis |
| 12/15/2004 | EP0988263B1 Process for the production of radioiodinated neuroreceptor agents |
| 12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
| 12/14/2004 | US6831180 Substituted tertiary carboxylic oxacycloalkane acids, used to prepare anhydro-homo-harringtonic acids by semi-synthesis; hydroxyl function of a cephalotaxane is esterified with a 2-carboxyl-2-alkyl-1-oxacycloalkane claimed intermediate; (indexing from 7169774 added) |
| 12/08/2004 | EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 12/08/2004 | EP1483263A1 Thiazolyl urea compounds for the treatment of cancer |
| 12/08/2004 | EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 12/08/2004 | EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/08/2004 | CN1553888A Biphenylene compounds |
| 12/07/2004 | US6828330 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 12/02/2004 | US20040242629 Quinuclidine carbamate derivatives and their use as M3 antagonists |
| 12/02/2004 | US20040242581 potent inhibitors of factor Xa which may have high bioavailability following oral administration |
| 12/01/2004 | EP1481975A1 Inhibitors of farnesyl protein transferase |
| 12/01/2004 | EP1480977A2 Substituted aryl compounds for treatment of disease |
| 12/01/2004 | EP1480954A1 Vanilloid receptor modulators |
| 11/25/2004 | US20040235887 Carbamates derived from arylalkylamines |
| 11/25/2004 | US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases |
| 11/24/2004 | EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative |
| 11/24/2004 | EP1478646A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
| 11/23/2004 | US6821998 Arylamines as inhibitors of chemokine binding to US28 |
| 11/23/2004 | US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases |